Swiss drone logistics company Matternet has announced that it will be working with the UK's National Health Service (NHS) on a project to deliver medical supplies in Central London.
The launch marks Matternet's first operations in the United Kingdom and a major step toward building a city-wide medical drone network for the NHS.
Operating in partnership with Apian, Matternet’s M2 drone system now connects two of Central London’s busiest hospital campuses through bi-directional aerial routes designed to move critical medical items in minutes.
The service will support the transport of diagnostic samples, laboratory specimens, pharmaceuticals and other time-sensitive payloads, helping reduce delays, improve hospital workflows and strengthen the resilience of healthcare logistics in one of the world’s most complex urban environments.
“We are proud to begin operations in Central London for the NHS,” said Andreas Raptopoulos, Founder and Chief Executive Officer of Matternet.
“This is a major milestone for Matternet and an important step toward building a city-wide medical drone network for one of the world’s leading healthcare systems. We believe ultra-fast logistics will become a core part of next-generation healthcare infrastructure, and in London we’re showing what that future will look like.”
Matternet already has operations in various states in North America (California, Florida, North Carolina and Utah included); in Germany, as well as its home country, Switzerland.
The company is one of the very few drone delivery companies to have achieved FAA Type Certification in the US, and one of the very few operators globally with routine commercial operations in urban environments.
“The UK is now home to world-class medical drone operations, leading the way in deploying innovative technologies to transform NHS patient care,” said Dr Zubir Ahmed, Health Innovation and Safety Minister.
“By connecting hospital campuses in minutes rather than hours, drone delivery means faster test results, quicker access to critical medical supplies, and better care for people who need it most.
“The NHS deserves world-class logistics to match its world-class staff, and today's launch shows what's possible when government, regulators and industry work together to make that happen. This is what modernising our health service actually looks like – shifting from analogue to digital as part of our 10 Year Health Plan.”
Matternet’s deployment builds on Apian’s broader success creating the autonomous logistics infrastructure layer for the NHS. By integrating autonomous drone delivery into hospital operations, the service is designed to move critical items faster, more reliably and with lower emissions than conventional ground transport through congested city streets.
“Matternet brings proven, world-class urban drone delivery capability to our platform at an important moment for the NHS,” said Alexander Trewby, Co-Founder and CEO of Apian.
“Together, we are building a new infrastructure layer for healthcare, where autonomous systems move critical items seamlessly between sites. In doing so, we are laying the foundations for physical AI to operate at scale in the real world, starting with the NHS.”
The launch follows close coordination with the UK Civil Aviation Authority and reflects the growing regulatory and institutional support for advanced drone logistics in the UK. As the network develops, Matternet and Apian expect to support additional hospital campuses, payload types and healthcare use cases across London. Together, the companies are laying the foundation for a future in which drone logistics become a seamless part of healthcare delivery across major urban healthcare systems.
Apian has also worked with drone company Wing for its autonomous healthcare systems provision operations. The company was co-founded by NHS doctors and connects hospitals, laboratories and pharmacies through a coordinated network of drones, ground robotics and orchestration software.
The system is designed to eliminate delays in the movement of critical items such as pathology samples, blood products and medications, improving clinical decision-making, operational efficiency and system resilience.